Martin A. Javors

Nature · 2009

⊕ Preprint · OA

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

▲ 3,732

Nature Cell Biology · 2015

⊕ Preprint · OA

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

▲ 1,095

Aging Cell · 2013

⊕ Open access · CC-BY

Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

▲ 634

Aging Cell · 2013

⊕ Open access · CC-BY

Acarbose, 17‐α‐estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males

▲ 462

Aging Cell · 2016

⊕ Open access · CC-BY

Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer

▲ 376

The Journals of Gerontology Series A · 2013

⊕ Open access · OA

Rapamycin Extends Life and Health in C57BL/6 Mice

▲ 283

PLoS ONE · 2014

⊕ Open access · CC-BY

Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome

▲ 149

Human Molecular Genetics · 2017

⊕ Open access · OA

Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome

▲ 90

Aging Cell · 2019

⊕ Open access · CC-BY

mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging

▲ 75

Aging Cell · 2022

⊕ Open access · CC-BY

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

▲ 67

Clinical Colorectal Cancer · 2020

⊕ Open access · OA

Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model

▲ 40

Pathobiology of Aging & Age-related Diseases · 2019

⊕ Open access · CC-BY

Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset

▲ 20